578 related articles for article (PubMed ID: 29471436)
1. Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS.
Ryan GE; Malik S; Mellon PL
Endocrinology; 2018 Apr; 159(4):1734-1747. PubMed ID: 29471436
[TBL] [Abstract][Full Text] [Related]
2. A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice.
Kauffman AS; Thackray VG; Ryan GE; Tolson KP; Glidewell-Kenney CA; Semaan SJ; Poling MC; Iwata N; Breen KM; Duleba AJ; Stener-Victorin E; Shimasaki S; Webster NJ; Mellon PL
Biol Reprod; 2015 Sep; 93(3):69. PubMed ID: 26203175
[TBL] [Abstract][Full Text] [Related]
3. Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome.
Arroyo P; Ho BS; Sau L; Kelley ST; Thackray VG
PLoS One; 2019; 14(9):e0223274. PubMed ID: 31568518
[TBL] [Abstract][Full Text] [Related]
4. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.
Mannerås L; Cajander S; Holmäng A; Seleskovic Z; Lystig T; Lönn M; Stener-Victorin E
Endocrinology; 2007 Aug; 148(8):3781-91. PubMed ID: 17495003
[TBL] [Abstract][Full Text] [Related]
5. Hyperactive LH Pulses and Elevated Kisspeptin and NKB Gene Expression in the Arcuate Nucleus of a PCOS Mouse Model.
Esparza LA; Schafer D; Ho BS; Thackray VG; Kauffman AS
Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32031594
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of GABA against metabolic and reproductive disturbances in letrozole induced polycystic ovarian syndrome in rats.
Ullah A; Jahan S; Razak S; Pirzada M; Ullah H; Almajwal A; Rauf N; Afsar T
J Ovarian Res; 2017 Sep; 10(1):62. PubMed ID: 28915843
[TBL] [Abstract][Full Text] [Related]
7. Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism.
Rajan RK; M SS; Balaji B
Pharm Biol; 2017 Dec; 55(1):242-251. PubMed ID: 27927075
[TBL] [Abstract][Full Text] [Related]
8. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
9. Relevance of an opioid, noscapine in reducing cystogeneses in rat experimental model of polycystic ovary syndrome.
Priyadarshani A
J Endocrinol Invest; 2009 Nov; 32(10):837-43. PubMed ID: 19609106
[TBL] [Abstract][Full Text] [Related]
10. Welsh Onion Root (
Lee YH; Yang H; Lee SR; Kwon SW; Hong EJ; Lee HW
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30287740
[TBL] [Abstract][Full Text] [Related]
11. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
[TBL] [Abstract][Full Text] [Related]
12. Developmental Programming: Insulin Sensitizer Prevents the GnRH-Stimulated LH Hypersecretion in a Sheep Model of PCOS.
Cardoso RC; Burns A; Moeller J; Skinner DC; Padmanabhan V
Endocrinology; 2016 Dec; 157(12):4641-4653. PubMed ID: 27792406
[TBL] [Abstract][Full Text] [Related]
13. Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome.
Du DF; Li XL; Fang F; Du MR
Gynecol Endocrinol; 2014; 30(12):885-9. PubMed ID: 25170777
[TBL] [Abstract][Full Text] [Related]
14. Cysteine-Cysteine Motif Chemokine Receptor 5 Expression in Letrozole-Induced Polycystic Ovary Syndrome Mice.
Seow KM; Liu PS; Chen KH; Chen CW; Chen LK; Ho CH; Hwang JL; Wang PH; Juan CC
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008567
[TBL] [Abstract][Full Text] [Related]
15. Low dose spironolactone-mediated androgen-adiponectin modulation alleviates endocrine-metabolic disturbances in letrozole-induced PCOS.
Olaniyi KS; Oniyide AA; Adeyanju OA; Ojulari LS; Omoaghe AO; Olaiya OE
Toxicol Appl Pharmacol; 2021 Jan; 411():115381. PubMed ID: 33359182
[TBL] [Abstract][Full Text] [Related]
16. Continuous administration of a P450 aromatase inhibitor induces polycystic ovary syndrome with a metabolic and endocrine phenotype in female rats at adult age.
Maliqueo M; Sun M; Johansson J; Benrick A; Labrie F; Svensson H; Lönn M; Duleba AJ; Stener-Victorin E
Endocrinology; 2013 Jan; 154(1):434-45. PubMed ID: 23183180
[TBL] [Abstract][Full Text] [Related]
17. Apelin receptor modulation mitigates letrozole-induced polycystic ovarian pathogenesis in mice.
Anima B; Gurusubramanian G; Roy VK
Cytokine; 2024 Jul; 179():156639. PubMed ID: 38733946
[TBL] [Abstract][Full Text] [Related]
18. Effects of electro-acupuncture on ovarian P450arom, P450c17α and mRNA expression induced by letrozole in PCOS rats.
Sun J; Jin C; Wu H; Zhao J; Cui Y; Liu H; Wu L; Shi Y; Zhu B
PLoS One; 2013; 8(11):e79382. PubMed ID: 24260211
[TBL] [Abstract][Full Text] [Related]
19. Ovulatory effects of flutamide in the polycystic ovary syndrome.
Paradisi R; Fabbri R; Battaglia C; Venturoli S
Gynecol Endocrinol; 2013 Apr; 29(4):391-5. PubMed ID: 23327685
[TBL] [Abstract][Full Text] [Related]
20. Deletion of Androgen Receptors From Kisspeptin Neurons Prevents PCOS Features in a Letrozole Mouse Model.
Decourt C; Watanabe Y; Evans MC; Inglis MA; Fisher LC; Jasoni CL; Campbell RE; Anderson GM
Endocrinology; 2023 Apr; 164(6):. PubMed ID: 37191144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
